Literature DB >> 8092307

Opioid growth factor inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner.

I S Zagon1, Y Wu, P J McLaughlin.   

Abstract

In addition to neuromodulation, endogenous opioids also serve as growth factors. To investigate the involvement of the naturally occurring opioid peptide [Met5]enkephalin [termed opioid growth factor (OGF)] in the renewal of epithelium, adult mice were given systemic injections of OGF (1 mg/kg) and examined 2 h later at 0700 or 1700 h. DNA synthesis in the tongue was investigated using [3H]thymidine and autoradiography. OGF depressed DNA synthesis of the basal epithelial cells in the tip, and dorsal and ventral surfaces of the tongue (42-44% of control levels) only at 0700 h. This decrease in DNA synthesis was blocked by concomitant administration of the opioid antagonist naloxone (10 mg/kg); naloxone alone had no influence on cell replicative processes. Both OGF and its receptor, zeta (zeta), were detected in the stratified squamous epithelium of the ventral and dorsal surfaces of the tongue by immunocytochemistry. Photodensitometric measurements of immunocytochemical preparations revealed almost twofold more OGF and zeta-receptor immunoreactivity at 1700 h than at 0700 h. These results indicate that an endogenous opioid peptide and its receptor are present and govern cellular renewal processes in the tongue and regulate DNA synthesis in a circadian rhythm-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092307     DOI: 10.1152/ajpregu.1994.267.3.R645

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Opioid growth factor and the treatment of human pancreatic cancer: a review.

Authors:  Ian S Zagon; Patricia J McLaughlin
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 2.  Intermittent blockade of OGFr and treatment of autoimmune disorders.

Authors:  Ian S Zagon; Patricia J McLaughlin
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

3.  The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.

Authors:  Fan Cheng; Patricia J McLaughlin; Michael F Verderame; Ian S Zagon
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

4.  The Novel Secreted Meloidogyne incognita Effector MiISE6 Targets the Host Nucleus and Facilitates Parasitism in Arabidopsis.

Authors:  Qianqian Shi; Zhenchuan Mao; Xiaoping Zhang; Jian Ling; Runmao Lin; Xi Zhang; Rui Liu; Yunsheng Wang; Yuhong Yang; Xinyue Cheng; Bingyan Xie
Journal:  Front Plant Sci       Date:  2018-03-23       Impact factor: 5.753

5.  Killing effect of methionine enkephalin on melanoma in vivo and in vitro.

Authors:  Dong-Mei Wang; Xue Jiao; Nicolas P Plotnikoff; Noreen Griffin; Rui-Qun Qi; Xing-Hua Gao; Feng-Ping Shan
Journal:  Oncol Rep       Date:  2017-08-24       Impact factor: 3.906

6.  High expression of proenkephalin is associated with favorable outcomes in patients with gastrointestinal stromal tumors.

Authors:  Defeng Tang; Tianlong Lin; Yangyang Wang; Hui Cao
Journal:  Cancer Manag Res       Date:  2019-07-17       Impact factor: 3.989

7.  The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer.

Authors:  Fan Cheng; Patricia J McLaughlin; Michael F Verderame; Ian S Zagon
Journal:  Mol Cancer       Date:  2008-01-11       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.